DBV Technologies SA (FRA:DBV)
€ 0.737 0.087 (13.38%) Market Cap: 71.09 Mil Enterprise Value: 34.75 Mil PE Ratio: 0 PB Ratio: 1.32 GF Score: 36/100

DBV Technologies SA at Goldman Sachs Global Healthcare Conference Transcript

Jun 12, 2019 / 03:40PM GMT
Release Date Price: €15.08 (-4.13%)
Graig Suvannavejh
Goldman Sachs - Analyst

Okay, good morning, everyone, and welcome to I believe it's the 8:40 session here at the Goldman Sachs Global Healthcare Conference. By introduction, my name is Graig Suvannavejh; I cover European biotech for the Firm and I'm seated out of London. It's my pleasure to introduce DBV Technologies today. With us is CEO Daniel Tassé and in the audience is Sara Sherman who is Senior Director of Investor Relations.

Questions & Answers

Graig Suvannavejh
Goldman Sachs - Analyst

So with that, Daniel, you are new to the company, CEO. Maybe if you could just tell us your thought process when you were thinking about opportunities, why DBV was the one that you were compelled to join.

Daniel TassÃ;DBV Technologies SA;CEO

©,-

Thank you and good morning, Graig. Look, I'm the poster child for the traditional pharmaceutical industry with a graduate degree in biochemistry, then took on commercial jobs and then after that strategy in jobs that intersect science

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot